Xiang Yuan Xiong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiang Yuan Xiong has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Zi Ling Li
School of Pharmaceutical Sciences, School of Life Science, Jiangxi Science and Technology Normal University, Nanchang 330013, China
13 shared publicationsYu Ping Li
School of Pharmaceutical Sciences, School of Life Science, Jiangxi Science and Technology Normal University, Nanchang 330013, China
12 shared publicationsYan Chun Gong
School of Pharmaceutical Sciences, School of Life Science, Jiangxi Science and Technology Normal University, Nanchang 330013, China
10 shared publicationsLiang Guo
School of life science, Jiangxi Science & Technology Normal University, Nanchang 330013, China
3 shared publicationsYue Yuan Luo
School of Life Science, Jiangxi Science and Technology Normal University, Nanchang 330013, China
3 shared publicationsZhi Yong Liu
Laboratory Animal Science and Technology Center, Jiangxi University of Traditional Chinese Medicine, Nanchang 330045, China
3 shared publications
Latest Publications
- 1 October 2019
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 139, 377-386
Folate-conjugated pluronic/polylactic acid polymersomes for oral delivery of paclitaxel
- 1 October 2019
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 139, 377-386
Folate-conjugated pluronic/polylactic acid polymersomes for oral delivery of paclitaxel
- 16 November 2018
- Published by Wiley in Macromolecular Bioscience
- Vol. 19 (2) , e1800348
Effect of the Folate Ligand Density on the Targeting Property of Folated‐Conjugated Polymeric Nanoparticles
Targeted drug delivery systems have attracted increasing attention due to their ability for delivering anticancer drugs selectively to tumor cells. Folic acid (FA)‐conjugated targeted block copolymers, FA‐Pluronic‐polycaprolactone (FA‐Pluronic‐PCL) are synthesized in this study. The anticancer drug paclitaxel (PTX) is loaded in FA‐Pluronic‐PCL nanoparticles by nanoprecipitation method. The in vitro release of PTX from FA‐Pluronic‐PCL nanoparticles shows slow and sustained release behaviors. The effect of FA ligand density of FA‐Pluronic‐PCL nanoparticles on their targeting properties is examined by both cytotoxicity and fluorescence methods. It is shown that FA‐Pluronic‐PCL nanoparticles indicated better targeting ability than non‐targeted PCL‐Pluronic‐PCL nanoparticles. Furthermore, FA‐F127‐PCL nanoparticle with 10% FA molar content has more effective antitumor activity and higher cellular uptake than those with 50% and 91% FA molar content. These results prove that FA‐F127‐PCL nanoparticle with 10% FA molar content can be a better candidate as the drug carrier in targeted drug delivery systems.
- 16 November 2018
- Published by Wiley in Macromolecular Bioscience
- Vol. 19 (2) , e1800348
Effect of the Folate Ligand Density on the Targeting Property of Folated‐Conjugated Polymeric Nanoparticles
Targeted drug delivery systems have attracted increasing attention due to their ability for delivering anticancer drugs selectively to tumor cells. Folic acid (FA)‐conjugated targeted block copolymers, FA‐Pluronic‐polycaprolactone (FA‐Pluronic‐PCL) are synthesized in this study. The anticancer drug paclitaxel (PTX) is loaded in FA‐Pluronic‐PCL nanoparticles by nanoprecipitation method. The in vitro release of PTX from FA‐Pluronic‐PCL nanoparticles shows slow and sustained release behaviors. The effect of FA ligand density of FA‐Pluronic‐PCL nanoparticles on their targeting properties is examined by both cytotoxicity and fluorescence methods. It is shown that FA‐Pluronic‐PCL nanoparticles indicated better targeting ability than non‐targeted PCL‐Pluronic‐PCL nanoparticles. Furthermore, FA‐F127‐PCL nanoparticle with 10% FA molar content has more effective antitumor activity and higher cellular uptake than those with 50% and 91% FA molar content. These results prove that FA‐F127‐PCL nanoparticle with 10% FA molar content can be a better candidate as the drug carrier in targeted drug delivery systems.
- 1 December 2017
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 105, 711-719
The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles
- 1 December 2017
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 105, 711-719
The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles
- 1 October 2017
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 103, 1011-1018
Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel
- 1 October 2017
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 103, 1011-1018
Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel
- Open Access
- 1 March 2017
- Published by Institution of Engineering and Technology (IET) in Micro & Nano Letters
- Vol. 12 (3) , 191-194
Synthesis, characterisation and in vitro release of paclitaxel‐loaded polymeric micelles
A novel folic acid (FA) poly (ethylene oxide) (PEO)/poly (lactic acid) (PLA) block copolymer conjugate (FA‐PEO‐PLA) was successfully synthesised by a two‐step reaction. FA‐PEO‐PLA can form mixed micelles with low critical micelle concentration (3.2 × 10 −3 wt%). The physical properties and the structure of micelles were characterised by size distribution and transmission electron microscopy. The micelles exhibited uniform spherical structure and the average diameter was 107.9 nm with narrow size distribution (polydispersity index 0.214). Paclitaxel was loaded in micelles and the encapsulation efficiency of paclitaxel was 43%. The in vitro release of paclitaxel from micelles was initially fast in the first 8 h followed by sustained release. The Weibull model was the most appropriate mechanism for describing the release procedure. These results indicated that the FA‐PEO‐PLA can be used as a carrier for hydrophobic anticancer drugs.
- 1 March 2017
- Published by Institution of Engineering and Technology (IET) in Micro & Nano Letters
- Vol. 12 (3) , 191-194
Open AccessSynthesis, characterisation and in vitro release of paclitaxel‐loaded polymeric micelles
A novel folic acid (FA) poly (ethylene oxide) (PEO)/poly (lactic acid) (PLA) block copolymer conjugate (FA‐PEO‐PLA) was successfully synthesised by a two‐step reaction. FA‐PEO‐PLA can form mixed micelles with low critical micelle concentration (3.2 × 10 −3 wt%). The physical properties and the structure of micelles were characterised by size distribution and transmission electron microscopy. The micelles exhibited uniform spherical structure and the average diameter was 107.9 nm with narrow size distribution (polydispersity index 0.214). Paclitaxel was loaded in micelles and the encapsulation efficiency of paclitaxel was 43%. The in vitro release of paclitaxel from micelles was initially fast in the first 8 h followed by sustained release. The Weibull model was the most appropriate mechanism for describing the release procedure. These results indicated that the FA‐PEO‐PLA can be used as a carrier for hydrophobic anticancer drugs.
- 25 May 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (58) , 52729-52738
Novel folated Pluronic/poly(lactic acid) nanoparticles for targeted delivery of paclitaxel
The purpose of this study was to explore the in vitro and in vivo targeting behaviors of novel folated Pluronic/poly(lactic acid) block copolymers (FA–Pluronic–PLA) for the anticancer drug, paclitaxel. Both paclitaxel-loaded FA–Pluronic–PLA nanoparticles show in vitro sustained release and in vivo prolonged circulation time. The in vitro actively targeting behavior of paclitaxel-loaded FA–Pluronic–PLA nanoparticles against OVCAR-3 cells (folate receptor positive) was proved by the cytotoxicity tests. The in vivo targeting properties of nanoparticles were also studied in OVCAR-3 ovarian tumor-bearing mice. It was observed that the tumor growth percentage for targeted paclitaxel-loaded FA–F127–PLA nanoparticles is lower than that for non-targeted paclitaxel-loaded PLA–F127–PLA nanoparticles. It was observed from FM images that FA–Pluronic–PLA nanoparticles are mainly localized within the cytoplasm of OVCAR-3 cells.
- 25 May 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (58) , 52729-52738
Novel folated Pluronic/poly(lactic acid) nanoparticles for targeted delivery of paclitaxel
The purpose of this study was to explore the in vitro and in vivo targeting behaviors of novel folated Pluronic/poly(lactic acid) block copolymers (FA–Pluronic–PLA) for the anticancer drug, paclitaxel. Both paclitaxel-loaded FA–Pluronic–PLA nanoparticles show in vitro sustained release and in vivo prolonged circulation time. The in vitro actively targeting behavior of paclitaxel-loaded FA–Pluronic–PLA nanoparticles against OVCAR-3 cells (folate receptor positive) was proved by the cytotoxicity tests. The in vivo targeting properties of nanoparticles were also studied in OVCAR-3 ovarian tumor-bearing mice. It was observed that the tumor growth percentage for targeted paclitaxel-loaded FA–F127–PLA nanoparticles is lower than that for non-targeted paclitaxel-loaded PLA–F127–PLA nanoparticles. It was observed from FM images that FA–Pluronic–PLA nanoparticles are mainly localized within the cytoplasm of OVCAR-3 cells.
- 11 June 2015
- Published by Taylor & Francis in Drug Delivery
- Vol. 23 (6) , 1-10
A review of biodegradable polymeric systems for oral insulin delivery
Currently, repeated routine subcutaneous injections of insulin are the standard treatment for insulin-dependent diabetic patients. However, patients’ poor compliance for injections often fails to achieve the stable concentration of blood glucose. As a protein drug, the oral bioavailability of insulin is low due to many physiological reasons. Several carriers, such as macromolecules and liposomes have been used to deliver drugs in vivo. In this review article, the gastrointestinal barriers of oral insulin administration are described. Strategies for increasing the bioavailability of oral insulin, such absorption enhancers, enzyme inhibitors, enteric coatings are also introduced. The potential absorption mechanisms of insulin-loaded nanoparticles across the intestinal epithelium, including intestinal lymphatic route, transcellular route and paracellular route are discussed in this review. Natural polymers, such as chitosan and its derivates, alginate derivatives, γ-PGA-based materials and starch-based nanoparticles have been exploited for oral insulin delivery; synthetic polymers, such as PLGA, PLA, PCL and PEA have also been developed for oral administration of insulin. This review focuses on recent advances in using biodegradable natural and synthetic polymers for oral insulin delivery along with their future prospects.
- 11 June 2015
- Published by Taylor & Francis in Drug Delivery
- Vol. 23 (6) , 1-10
A review of biodegradable polymeric systems for oral insulin delivery
Currently, repeated routine subcutaneous injections of insulin are the standard treatment for insulin-dependent diabetic patients. However, patients’ poor compliance for injections often fails to achieve the stable concentration of blood glucose. As a protein drug, the oral bioavailability of insulin is low due to many physiological reasons. Several carriers, such as macromolecules and liposomes have been used to deliver drugs in vivo. In this review article, the gastrointestinal barriers of oral insulin administration are described. Strategies for increasing the bioavailability of oral insulin, such absorption enhancers, enzyme inhibitors, enteric coatings are also introduced. The potential absorption mechanisms of insulin-loaded nanoparticles across the intestinal epithelium, including intestinal lymphatic route, transcellular route and paracellular route are discussed in this review. Natural polymers, such as chitosan and its derivates, alginate derivatives, γ-PGA-based materials and starch-based nanoparticles have been exploited for oral insulin delivery; synthetic polymers, such as PLGA, PLA, PCL and PEA have also been developed for oral administration of insulin. This review focuses on recent advances in using biodegradable natural and synthetic polymers for oral insulin delivery along with their future prospects.
- 1 November 2013
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 111, 282-288
Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery
- 1 November 2013
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 111, 282-288
Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery
- 1 August 2012
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 46 (5) , 537-544
In vitro & in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin–avidin interaction
- 1 August 2012
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 46 (5) , 537-544
In vitro & in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin–avidin interaction
- 1 January 2011
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 22 (12) , 1607-1619
Active Targeting Behaviors of Biotinylated Pluronic/Poly(Lactic Acid) Nanoparticles In Vitro through Three-Step Biotin–Avidin Interaction
In order to prepare targeted drug carriers, previously a biotin group has been attached by our group to the end of Pluronic F87/poly(lactic acid) and Pluronic P85/poly(lactic acid) block co-polymer...
- 1 January 2011
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 22 (12) , 1607-1619
Active Targeting Behaviors of Biotinylated Pluronic/Poly(Lactic Acid) Nanoparticles In Vitro through Three-Step Biotin–Avidin Interaction
In order to prepare targeted drug carriers, previously a biotin group has been attached by our group to the end of Pluronic F87/poly(lactic acid) and Pluronic P85/poly(lactic acid) block co-polymer...